Anebulo Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Anebulo Pharmaceuticals using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-11-13 | $-0.05 | $-0.12 | 58.3 % |
| Q4 | 2025-09-29 | $-0.05 | $-0.05 | 0.00 % |
| Q3 | 2025-05-13 | $-0.04 | $-0.05 | 20.0 % |
| Q2 | 2025-02-14 | $-0.09 | $-0.08 | -12.5 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
Anebulo Pharmaceuticals (ANEB) is scheduled to report earnings on February 13, 2026. The last reported earnings were for reported on November 13, 2025 for Q1.
The Actual EPS was $-0.05, which beat the estimate of $-0.12.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.